Skip to main content
logo
YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
3.240
-0.460 (-12.43%)
At close: Sep 17, 2026, 4:00 PM EDT
3.190
-0.050 (-1.54%)
After-hours: Sep 17, 2026, 7:30 PM EDT

YD Bio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1.240.60.510.350.36
Revenue Growth
147.92%16.94%45.76%-3.84%-
Gross Profit
0.370.170.160.150.13
Operating Income
-6.55-5.27-1.46-0.01-0.04
Net Income
0.31-8.31-1.410.01-0.05
Earnings Per Share
0.00-0.12-1.290.01-
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
2.666.013.130.090.03
Total Debt
0.010.010.020.050.12
Net Cash (Debt)
2.6663.110.04-0.09
Net Cash Growth
-92.95%7769.12%--
Net Cash Per Share
0.040.092.840.04-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-7.26-6.6-1.84-0.060.07
Capital Expenditures
-1.45-1.44-0.07-0-
Free Cash Flow
-8.7-8.04-1.91-0.060.07
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
29.60%28.05%30.44%43.82%36.58%
Operating Margin
-528.73%-883.31%-286.45%-2.81%-12.33%
Pretax Margin
24.67%-1392.86%-271.67%5.04%-13.30%
Profit Margin
24.67%-1392.61%-276.58%3.87%-13.95%
FCF Margin
-702.15%-1346.60%-374.58%-15.98%19.21%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
PE Ratio
745.14--3497.13-
P/FCF Ratio
----720.26
PS Ratio
183.841436.2888.92135.44138.36